Decreased Efficiency of Neutralizing Antibodies from Previously Infected or Vaccinated Individuals against the B.1.617.2 (Delta) SARS-CoV-2 Variant
ABSTRACT The neutralizing antibody response is a key component of adaptive immunity and a primary protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The increased transmissibility of the SARS-CoV-2 Delta variant and its capacity to cause more severe disease co...
Main Authors: | Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Caroline Gernigon, Marion Porcheron, Sabine Chapuy-Regaud, Jacques Izopet |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-08-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.02706-21 |
Similar Items
-
Antibody Titers and Protection against Omicron (BA.1 and BA.2) SARS-CoV-2 Infection
by: Chloé Dimeglio, et al.
Published: (2022-09-01) -
Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01) -
Histopathological Lung Findings in COVID-19 B.1.617.2 SARS-CoV-2 Delta Variant
by: Ionuț Isaia Jeican, et al.
Published: (2023-01-01) -
SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
by: Kym Lowry, et al.
Published: (2022-08-01) -
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
by: Manish Dhawan, et al.
Published: (2022-11-01)